top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances and Novel Treatment Options in Metastatic Melanoma
Advances and Novel Treatment Options in Metastatic Melanoma
Autore Facchiano Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (528 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato ABT-737
acetazolamide
acetylcholine
adjuvant therapy
amoeboid motility
angiogenesis
apoptosis
arthralgia
Bcl-2 family
BCL2L10
biomarkers
BRAF
BRAF inhibitor
BRAF inhibitors
BRAF-mutant melanoma
cancer
cancer associated fibroblast
cancer stem cells
carbonic anhydrase
cell therapy
checkpoint inhibitor
cholinergic system
combined therapy
ctDNA
CXCL10
cyclopamine
cytokines
cytotoxicity
diagnosis
DOCK4
drug resistance
essential oils
exosomes
extracellular vesicles
FAK
hedgehog
HIPPO
HuR
immunity
immunotherapy
interferon
invasion
ipilimumab
lactate dehydrogenase
lipid metabolism
liquid biopsy
liver-directed-therapies
machine learning
MANS peptide
MARCKS
mechanism of action
melanoma
melanoma immune infiltrate
melanoma markers
melanoma metastasis
melanoma PDX
melanomagenesis
metalloproteinases
metastases
metastasis
metastatic dormancy
metastatic therapy
metastatic uveal melanoma (mUM)
microenvironment
microRNAs
MITF
ML258
motility
mucosal melanoma
muscarinic receptors
n/a
nanoparticles
nicotinic receptors
nivolumab
OXPHOS
patient stratification
PD-1
pembrolizumab
phosphorylation
plasmacytoid dendritic cells
prediction
principal component analysis
prognosis
prognostication
protein tyrosine phosphatase
PTPs inhibitors
Rac1
radiotherapy
resistance
rheumatoid arthritis
sex-hormones
sex/gender
ShcD adaptor protein
siRNA
slow cycling phenotype
small molecules
SOCE
STAT3
Support Vector Machine
survival
target therapy
targeted therapy
targeted-therapy
therapeutic resistance
therapy
TLR
TPC2
tumor microenvironment
tumour microenvironment
uveal melanoma (UM)
WNT5A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557612103321
Facchiano Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (284 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato acetylation
actin cytoskeletal reorganization
adaptive immunity
advanced ovarian cancer
anti-receptor therapy
BET inhibitors
biomarkers
bladder cancer initiation
breast cancer
CALR
cancer
cancer immunology
cancer therapeutics
carcinogenicity
CD99 agonist
complement system
DUSP1
EGFR dimerization
endocytosis
epigenetic
epigenome
epithelial cells
FAK dephosphorylation
genome
glioblastoma
gp120
hepatocellular carcinoma
human immunodeficiency virus type 1
immune checkpoint inhibitors
immune evasion
immunotherapy
innate immunity
JAK2
luminal breast cancer
MAPK
matrix protein p17
metastasis
metastatic melanoma
methylation
migration and invasion
mitochondria
molecular targeted agents
MPL
MS-determined phosphopeptides
mTOR
myeloproliferative neoplasms
n/a
Nef
NIMA-related kinase 1 (NEK1)
non-coding RNA
OMD
oncogenic signaling pathway
ovarian cancer
oxidative stress
OXPHOS
pancreatic ductal adenocarcinoma
partial EMT
patient survival
pBRD4
PI3K
PP2A
PRELP
prognosis
prostate cancer
PTPN12
Rac1
reactive oxygen species
resistance
reverse transcriptase
RhoA
SET
signaling pathways
small-cell lung cancer
Snail
splicing pathway
TAK-228
Tat
thioridazine (THD)
tight junction
tousled-like kinase (TLK)
TPOR
trastuzumab
tripeptide
triple negative breast cancer
triple-negative breast cancer
tumor immune microenvironment
tumor microenvironment
tumor suppression gene
Warburg effect
yes-associated protein 1 (YAP1)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui